Deals Of The Week Ponders Project Financing

 
• By Michael Goodman, Stacy Lawrence, and Jessica Merrill

GSK has been out ahead of other big pharmas when it comes to investing in venture funds. Its deal with Avalon Ventures adds a new twist – investing as a partner rather than an LP and creating single-asset companies. Plus other notable deals involving Merck, AstraZeneca, Opko Health and more . . .

More from Archive

More from Pink Sheet